Get the Stockscreener App
18.46
6.03%
1.05
After Hours:
18.46
Yd Bio Ltd stock is traded at $18.46, with a volume of 29,335.
It is up +6.03% in the last 24 hours and down -20.12% over the past month.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
See More
Previous Close:
$17.41
Open:
$17.61
24h Volume:
29,335
Relative Volume:
0.56
Market Cap:
$1.30B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.43%
1M Performance:
-20.12%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$17.61
$18.48
1-Week Range:
$17.00
$19.49
52-Week Range:
$12.51
$25.00
Yd Bio Ltd Stock (YDES) Company Profile
Compare YDES with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
YDES
Yd Bio Ltd
|
18.46 | 1.23B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Yd Bio Ltd Stock (YDES) Latest News
Metals & Mining Virtual Investor Conference: Presentations Now Available for Online Viewing - The Manila Times
CAP Accreditation Secured: YD Bio partner EG BioMed's CLIA lab in Bothell bolsters U.S. cancer testing capabilities - Stock Titan
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results - BioSpace
MARTEN TRANSPORT CLOSES ON THE SALE OF ASSETS RELATED TO INTERMODAL BUSINESS - The Manila Times
Hub Group Closes on the Acquisition of Marten Transport Intermodal - The Manila Times
Three Small-Caps Took Off On News And Fresh Deals - Finimize
YD Bio announces COO resignation and updates on public warrant registration By Investing.com - Investing.com Nigeria
YD Bio announces COO resignation and updates on public warrant registration - Investing.com
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market SessionApellis Pharmaceuticals (NASDAQ:APLS), Concentrix (NASDAQ:CNXC) - Benzinga
Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday - Benzinga
Xinhua Finance: Chongqing’s Intelligent Bionic Robot Competition Highlights Advances in “Evolving” Robotics - digitalmore.co
New Mountain Finance, Texas Instruments, Analog… - inkl
Why Check-Cap Shares Are Trading Higher By 183%; Here Are 20 Stocks Moving Premarket - Benzinga
We're Keeping An Eye On YD Bio's (NASDAQ:YDES) Cash Burn Rate - 富途牛牛
Why Oxford Industries Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - inkl
Breeze Holdings Acquisition (YDES) Rises 31% Over the Past Month - simplywall.st
Why Did YD Bio Plunge 14.37% Despite Revenue Growth? - AInvest
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Benzinga
YD Bio Limited shares rise 7.33% premarket after being added to NASDAQ. - AInvest
Yd Bio Limited shares rise 56.25% intraday after being added to NASDAQ. - AInvest
YD Bio Stock Fuels Retail-Trader Excitement After Nasdaq Listing Through Breeze SPAC Deal - Asianet Newsable
YD Bio Limited Announces Closing of Business Combination - citybiz
YDES Stock Price and Chart — NASDAQ:YDES - TradingView
YDESBreeze Holdings Latest Stock News & Market Updates - Stock Titan
YD Bio's Nasdaq Debut: A Strategic SPAC Merger Positions the Biotech Innovator for High-Growth Catalysts - AInvest
Nasdaq: YD Bio Completes Merger With Breeze - AInvest
YD Bio Shares to Begin Trading on Nasdaq After Completing Merger With Breeze - MarketScreener
YD Bio Limited begins trading on Nasdaq under YDES, YDESW symbols. - AInvest
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market - PR Newswire
Cancer Detection Biotech YD Bio Debuts on Nasdaq: DNA Methylation Pioneer Raises $11.5M for Expansion - Stock Titan
Cancer Detection Biotech YD Bio Goes Public: $11.5M SPAC Deal Powers DNA Methylation Technology - Stock Titan
Taiwan Biotech YD Biopharma Secures Path to Nasdaq Through Breeze Holdings SPAC Merger Approval - Stock Titan
Reintegration of blastema and stump by reciprocal interaction for functional joint regeneration in frogs - ScienceDirect.com
Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan - BioSpectrum Asia
Ventral-to-dorsal electrocyte development in electric organs of electric eel (Electrophorus) - ScienceDirect.com
Reproductive adaptation of Astyanax mexicanus under nutrient limitation - ScienceDirect.com
Avian bioresources for developmental biology: Chicken and quail resources in the United Kingdom, France, and Japan - ScienceDirect.com
Breeze Holdings Acquisition To Merge with YD Biopharma - citybiz
MARKET DATA - The Wall Street Journal
US Share Prices - London South East
From neural tube to spinal cord: The dynamic journey of the dorsal neuroepithelium - ScienceDirect.com
Boron homeostasis affects Longan yield: a study of NIP and BOR boron transporter of two cultivars - BMC Plant Biology
Cardiac competence of the paraxial head mesoderm fades concomitant with a shift towards the head skeletal muscle programme - ScienceDirect.com
The heparan sulfate modification enzyme, Hs6st1, governs Xenopus neuroectodermal patterning by regulating distributions of Fgf and Noggin - ScienceDirect.com
Mechanism underlying retinoic acid-dependent metamorphosis in the starfish - ScienceDirect.com
Site pleiotropy of a stickleback Bmp6 enhancer - ScienceDirect.com
Polarity proteins: Shaping dendritic spines and memory - ScienceDirect.com
Reflections on the past, present and future of developmental biology - ScienceDirect.com
Yd Bio Ltd Stock (YDES) Financials Data
There is no financial data for Yd Bio Ltd (YDES). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):